Evonik Evonik

X

Find Odiparcil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Odiparcil
Also known as: 137215-12-4, Odiparcil [inn], Fik1414zi8, Gsk 424323, 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-beta-d-xylopyranosyl)oxy]-, 4-methyl-7-(((2r,3r,4s,5s)-3,4,5-trihydroxytetrahydro-2h-thiopyran-2-yl)oxy)-2h-chromen-2-one
Molecular Formula
C15H16O6S
Molecular Weight
324.4  g/mol
InChI Key
JRHNIQQUVJOPQC-AQNFWKISSA-N
FDA UNII
FIK1414ZI8

1 2D Structure

Odiparcil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-methyl-7-[(2R,3R,4S,5S)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one
2.1.2 InChI
InChI=1S/C15H16O6S/c1-7-4-12(17)21-11-5-8(2-3-9(7)11)20-15-14(19)13(18)10(16)6-22-15/h2-5,10,13-16,18-19H,6H2,1H3/t10-,13+,14-,15-/m1/s1
2.1.3 InChI Key
JRHNIQQUVJOPQC-AQNFWKISSA-N
2.1.4 Canonical SMILES
CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O
2.1.5 Isomeric SMILES
CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H](CS3)O)O)O
2.2 Other Identifiers
2.2.1 UNII
FIK1414ZI8
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 137215-12-4

2. Odiparcil [inn]

3. Fik1414zi8

4. Gsk 424323

5. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-beta-d-xylopyranosyl)oxy]-

6. 4-methyl-7-(((2r,3r,4s,5s)-3,4,5-trihydroxytetrahydro-2h-thiopyran-2-yl)oxy)-2h-chromen-2-one

7. Odiparcil [who-dd]

8. Dsstox_cid_31428

9. Dsstox_rid_97314

10. Unii-fik1414zi8

11. Dsstox_gsid_57639

12. Schembl4515803

13. Chembl2107763

14. Dtxsid4057639

15. Tox21_113853

16. Zinc31597280

17. 4-methyl-7-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one

18. Db06609

19. Gsk-424323

20. Ncgc00253734-01

21. Bo167288

22. Sb 424323

23. Cas-137215-12-4

24. E98880

25. Q27278001

26. 4-methyl-7-(5-thio-beta-d-xylopyranosyloxy)-2h-chromen-2-one

27. 4-methyl-2-oxo-2h-1-benzopyran-7-yl 5-thio-beta-d-xylopyranoside

28. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-b-d-xylopyranosyl)oxy]-

29. 4-methyl-7-(5-thio-.beta.-d-xylopyranosyloxy)-2h-chromen-2-one

30. 7-((2r,3r,4s,5s)-tetrahydro-3,4,5-trihydroxy-2h-thiopyran-2-yloxy)-4-methyl-2h-chromen-2-one

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 324.4 g/mol
Molecular Formula C15H16O6S
XLogP30.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count2
Exact Mass324.06675940 g/mol
Monoisotopic Mass324.06675940 g/mol
Topological Polar Surface Area122 Ų
Heavy Atom Count22
Formal Charge0
Complexity467
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in atrial fibrillation, cardiovascular disorders, thrombosis, and venous thromboembolism.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY